CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ALIVE project seeks to develop a technology for isolating extracellular vesicles from biological samples to identify non-invasive biomarkers for non-alcoholic fatty liver disease. This approach aims to improve diagnostics without the need for invasive procedures.
Non-alcoholic fatty liver disease (NAFLD) is a disease of alarmingly increasing prevalence, associated with metabolic and cardiovascular complications and morbid mortality.
The disease spectrum covers from a simple steatosis to non-alcoholic steatohepatitis (NASH).
With estimated 25% of population having NAFLD, it makes it the most common liver disease in the world.
While diagnosing and stratifying NAFLD and NASH is of high priority to identify subjects with increased risk for cardio-vascular c…
EXIT071 BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
